logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Ovarian cancer: upfront bevacizumab fails improve overall survival in phase 3

Exploratory analysis suggests survival benefit in BRCA subsets.